分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Study on Drug Resistance to Tumor Cell in Oxygen Gradient and Co-culture Microfluidic Chip

Wei SUN, Yu-Qing CHEN, Ming-Fang WANG, Yue-Rong WANG, Min ZHANG, Hong-Yang ZHANG, Ping HU

Journal:CHINESE JOURNAL OF ANALYTICAL CHEMISTRY

IF:0.94

DOI:10.1016/S1872-2040(19)61214-4

PMID:

Published:2020-02-05

research field:毒理学药理学心血管疾病结构生物学微生物学生物化学

Abstract

The tumor microenvironment is a complex system that plays a vital role in proliferation, invasion and metastasis. In this work, an oxygen concentration gradient microfluidic chip was designed to construct an in vitro model of tumor hypoxic microenvironment. The microfluidic chip was composed of two parts, one was a serpentine-shape channel for hypoxia reagent mix to generate oxygen gradient, the other part contained three parallel channels for the co-culture of cancer cells (Heap1-6 cells) and hepatic stellate cells (JS-1 cells). Using the microfluidic chip, oxygen gradient was created under the culture condition to simulate hypoxic tumor microenvironment in vivo . In the hypoxic gradient environment, the drug resistance of Hepa1-6 cells to paclitaxel and tirapazamine (TPZ) was studied and the potential molecular mechanism was supposed. The results showed that the concentration of oxygen gradient ranged from 2.3% to 16.7%. Under this hypoxic condition, the viability of co-cultured Hepa1-6 cells decreased significantly under TPZ intervention, while the Hepa1-6 cells expressed resistance to paclitaxel. The results of immunofluorescence assay showed that hypoxia and co-culture condition could promote the expression of TIMP-1 and TGF- β , which induced the activation of JS-1 cell and further enhanced the drug resistance of Hepa1-6 cell to paclitaxel.

本文使用的Yeasen产品

购物车
客服
转染试用